glp-1 obesity drug news today september 15 2025 Alarming rise in weight loss overdoses Use of diabetes and anti-obesity

Insulin Secretion Models: Investigating glucose-dependent signaling pathways

Zudem zeigen Studien, dass nach dem Absetzen der Therapie hufig ein Jo-Jo-Effekt eintritt das verlorene Gewicht kehrt zurck, wenn keine tiefgreifende Lebensstilnderung erfolgt

[DOI] [PubMed] [Google Scholar] 171

2024 State Action Late last year, Illinois adopted a bill to cover certain weight loss and obesity medicines, including GLP-1s, under the state employee health plan

However, data on the glycaemic benefits of perioperative GLP-1 RAs suggest that restarting these medications in the postoperative setting might be desirable in a select cohort of patients who are able to resume their usual diets, and do not have gastrointestinal symptoms

2017;5:e13102